Torii Pharmaceutical Co Ltd 2023 IR
The report outlines Torii Pharmaceutical's strategic transition to a phase of accelerated growth and its first publication of an Integrated Report for fiscal year 2023. The company achieved net sales of 54.6 billion yen, driven by strong sales of skin disease and allergen products, and updated its VISION2030 net sales target to over 80.0 billion yen. Key milestones included transitioning to a company with an Audit and Supervisory Committee to enhance corporate governance and establishing a new Source Materials Procurement Department to secure cedar pollen supply. Additionally, the company identified eleven material issues and advanced its climate change initiatives by initiating scenario analyses aligned with the TCFD framework.
Company: Torii Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2023
Type: IR
Pages: 55
Torii Pharmaceutical Co Ltd
Integrated Report
The report outlines Torii Pharmaceutical's strategic transition to a phase of accelerated growth and its first publication of an Integrated Report for fiscal year 2023. The company achieved net sales of 54.6 billion yen, driven by strong sales of skin disease and allergen products, and updated its VISION2030 net sales target to over 80.0 billion yen. Key milestones included transitioning to a company with an Audit and Supervisory Committee to enhance corporate governance and establishing a new Source Materials Procurement Department to secure cedar pollen supply. Additionally, the company identified eleven material issues and advanced its climate change initiatives by initiating scenario analyses aligned with the TCFD framework.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Total Waste
Women on Board
Women in Management
Employees